7.7 Conclusions
In accordance with the complex immunopathological findings in AD, many different murine models have been established, each focusing on different aspects of the disease. Thus several transgenic and knockout mouse models were helpful to a certain degree in improving our understanding of AD pathophysiology. However, genetic manipulation of a single cytokine obviously cannot mirror the whole picture of a complex disease such as AD. Neither the interaction between selected cytokines nor the entire pathological pathways can be completely evaluated with these models. Yet this type of mouse model has great potential for increasing our knowledge of AD pathology and for investigating the mechanisms of drug activities. Mice with spontaneous mutations resulting in an AD phenotype allow investigations on a broader scale, as do animals treated with antigens in order to induce AD. Combinations of the different approaches increase the size and versatility of the toolkit available, as shown by deletion of genes in NC/Nga mice, thus allowing even deeper insights in the mechanism of AD. Mice with a spontaneous AD phenotype are also suitable for drug testing and development. This also applies to the chimeric SCID-hu mouse, which allows assessment of the interaction between human skin and selected human cell populations. However, models should be chosen carefully and manipulations should be done only after appropriate consideration of side effects or unwanted additional effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, and Matsuda H (2001) Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 144:12–18
Akdis CA and Akdis M (2003) Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin Exp Allergy 33:1618–1621
Alenius H, Laouini D, Woodward A, Mizoguchi E, Bhan AK, Castigli E, Oettgen HC, and Geha RS (2002) Mast cells regulate IFNγ expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J Allergy Clin Immunol 109:106–113
Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, and Payan D (1996) Skin-nervous system interactions. J Invest Dermatol 106:198–204
Biedermann T, Schwarzler C, Lametschwandtner G, Thoma G, Carballido-Perrig N, Kund J, de Vries JE, Rot A, and Carballido JM (2002) Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 32:3171–3180
Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530
Bossie A, Vitetta ES (1991) IFNγ enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFNγ in class switching. Cell Immunol 135:95–104
Boyce JA (2003) Mast cells: beyond IgE. J Allergy Clin Immunol 111:24–32
Breuer K, Wittmann M, Bosche B, Kapp A, and Werfel T (2000) Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 55:551–555
Brown MA and Hural J (1997) Functions of IL-4 and control of its expression. Crit Rev Immunol 17:1–32
Bunikowski R, Mielke ME, Skarabis H, Worm M, Anagnostopoulos I, Kolde G, Wahn U, and Renz H (2000) Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 105:814–819
Carballido JM, Biedermann T, Schwarzler C, and de Vries JE (2003) The SCID-hu Skin mouse as a model to investigate selective chemokine mediated homing of human T-lymphocytes to the skin in vivo. J Immunol Methods 273:125–135
Chan LS, Robinson N, and Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977–983
Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, and Leung DY (2001) Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol 116:658–663
Chomarat P and Banchereau J (1997) An update on interleukin-4 and its receptor. Eur Cytokine Netw 8:333–344
Chomarat P and Banchereau J (1998) Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 17:1–52
Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, and Galli SJ (1996) Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681–2686
Dinarello CA and Fantuzzi G (2003) Interleukin-18 and host defense against infection. J Infect Dis 187[Suppl 2]:S370–S384
Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, and Sampson HA (1998) Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 101:E8
Elbe-Burger A, Egyed A, Olt S, Klubal R, Mann U, Rappersberger K, Rot A, and Stingl G (2002) Overexpression of IL-4 alters the homeostasis in the skin. J Invest Dermatol 118:767–778
Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S, Bron C, Tschopp J, and Thome M (2002) CARMA1 is a critical lipid graft-associated regulator of TCR-induced NF-κB activation. Nat Immunol 3:836–843
Galli SJ, Wedemeyer J, and Tsai M (2002) Analyzing the roles of mast cells and basophils in host defense and other biological responses. Int J Hematol 75:363–369
Gluckman JC, Canque B, Chapuis F, and Rosenzwajg M (1997) In vitro generation of human dendritic cells and cell therapy. Cytokines Cell Mol Ther 3:187–196
Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, and Braciale TJ (1993) Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J Exp Med 178:1725–1732
Grewal IS and Flavell RA (1996) The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 153:85–106
Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A, Ruzicka T, Schopf E, and Krutmann J (1998) Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 161:415–420
Habu Y, Seki S, Takayama E, Ohkawa T, Koike Y, Ami K, Majima T, and Hiraide H (2001) The mechanism of a defective IFNγ response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFNγ, IL-12, or IL-18 on dermatitis. J Immunol 166:5439–5447
Hagermark O, Rajka G, and Bergvist U (1972) Experimental itch in human skin elicited by rat mast cell chymase. Acta Derm Venereol 52:125–128
Hanissian SH and Geha RS (1997) Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379–387
Hara H, Wada T, Bakal C, Kozieradzki I, Suzuki S, Suzuki N, Nghiem M, Griffiths EK, Krawczyk C, Bauer B, D’Acquisto F, Ghosh S, Yeh WC, Baier G, Rottapel R, and Penninger JM (2003) The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18:763–775
Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, and Matsushima K (1999) Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 94:845–852
He S and Walls AF (1998a) Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 125:1491–1500
He S and Walls AF (1998b) The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 352:91–98
Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, and Mackay CR (1997) Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 99:178–184
Hershey GK, Friedrich MF, Esswein LA, Thomas ML, and Chatila TA (1997) The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 337:1720–1725
Hidalgo LG and Halloran PF (2002) Role of IFNγ in allograft rejection. Crit Rev Immunol 22:317–349
Ihle JN and Kerr IM (1995) Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11:69–74
Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, and Yoshie O (1997) The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272:15036–15042
Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, and Yoshie O (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81–88
Jeong CW, Ahn KS, Rho NK, Park YD, Lee DY, Lee JH, Lee ES, and Yang JM (2003) Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 33:1717–1724
Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, Hage-Hamsten M, and Wuthrich B (2001) A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56:813–824
Jun JE and Goodnow CC (2003) Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nat Immunol 4:1057–1064
Jun JE, Wilson LE, Vinuesa CG, Lesage S, Blery M, Miosge LA, Cook MC, Kucharska EM, Hara H, Penninger JM, Domashenz H, Hong NA, Glynne RJ, Nelms KA, and Goodnow CC (2003) Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18: 751–762
Kaplan AP (2001) Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol 124:423–431
Kaplan MH, Schindler U, Smiley ST, and Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313–319
Kieffer M, Bergbrant IM, Faergemann J, Jemec GB, Ottevanger V, Stahl SP, and Svejgaard E (1990) Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 22: 739–742
Kinaciyan T, Natter S, Kraft D, Stingl G, and Valenta R (2002) IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J Allergy Clin Immunol 109:717–719
Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, and Brown JM (1995) DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178–1183
Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, and Chi DS (2001) The human mast cell: functions in physiology and disease. Front Biosci 6:D1109–D1127
Kung TT, Stelts D, Zurcher JA, Jones H, Umland SP, Kreutner W, Egan RW, and Chapman RW (1995) Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 12:404–409
Laman JD, Claassen E, and Noelle RJ (1996) Functions of CD40 and its ligand, gp39 (CD40L). Crit Rev Immunol 16:59–108
Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, and Geha RS (2003) IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 112:1058–1066
Leung DY (2000) Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105:860–876
Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, and Sampson HA (1993) Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92:1374–1380
Leung DY, Hauk P, Strickland I, Travers JB, and Norris DA (1998) The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol 139[Suppl 53]: 17–29
Lever R, MacDonald C, Waugh P, and Aitchison T (1998) Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 9:13–19
Leyden JJ, Marples RR, and Kligman AM (1974) Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90:525–530
Li XM, Kleiner G, Huang CK, Lee SY, Schofield B, Soter NA, and Sampson HA (2001) Murine model of atopic dermatitis associated with food hypersensitivity. J Allergy Clin Immunol 107:693–702
Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, and Schechter NM (1997) Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 94:9017–9021
Ma W, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, Alenius H, Friend DS, Oettgen HC, Gerard C, and Geha RS (2002) CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109:621–628
Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, and Gately MK (1996) IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 4:471–481
Martin R (2003) Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases? Trends Pharmacol Sci 24:613–616
Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, and Ra C (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461–466
Matsumoto M, Ra C, Kawamoto K, Sato H, Itakura A, Sawada J, Ushio H, Suto H, Mitsuishi K, Hikasa Y, and Matsuda H (1999) IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/ Nga mice, a model for human atopic dermatitis. J Immunol 162:1056–1063
Matsuoka H, Maki N, Yoshida S, Arai M, Wang J, Oikawa Y, Ikeda T, Hirota N, Nakagawa H, and Ishii A (2003) A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 58:139–145
Mehling A, Loser K, Varga G, Metze D, Luger TA, Schwarz T, Grabbe S, and Beissert S (2001) Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 194:615–628
Mihm MC, Jr., Soter NA, Dvorak HF, and Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67:305–312
Moore KW, de Waal MR, Coffman RL, and O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765
Moore KW, O’Garra A, de Waal MR, Vieira P, and Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190
Nagai H, Yamaguchi S, Maeda Y, and Tanaka H (1996) Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin Exp Allergy 26:642–647
Natori K, Tamari M, Watanabe O, Onouchi Y, Shiomoto Y, Kubo S, and Nakamura Y (1999) Mapping of a gene responsible for dermatitis in NOA (Naruto Research Institute Otsuka Atrichia) mice, an animal model of allergic dermatitis. J Hum Genet 44:372–376
Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, and Leung DY (2003 a) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112:1195–1202
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, and Leung DY (2003b) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262–3269
Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, and Boyce JA (1999) T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190:267–280
Piloto VL, Gomez Echevarria AH, Valdes Sanchez AF, Ochoa OC, Chong LA, and Mier NG (1990) Atopic dermatitis. Findings of skin biopsies. Allergol Immunopathol (Madr) 18:321–324
Pomerantz JL, Denny EM, and Baltimore D (2002) CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex. EMBO J 21:5184–5194
Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, and Nelms K (1995) Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 15:3336–3343
Remitz A, Kyllonen H, Granlund H, and Reitamo S (2001) Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 107:196–197
Ruzicka T (1998) Atopic eczema between rationality and irrationality. Arch Dermatol 134:1462–1469
Sallusto F, Mackay CR, and Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005–2007
Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, and Lanzavecchia A (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29:1617–1625
Sampson HA (1999) Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 103:717–728
Sampson HA (2001) Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 107:891–896
Sasakawa T, Higashi Y, Sakuma S, Hirayama Y, Sasakawa Y, Ohkubo Y, Goto T, Matsumoto M, and Matsuda H (2001) Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 126:239–247
Scalabrin DM, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TA, and Wheatley LM (1999) Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 104:1273–1279
Schon MP, Zollner TM, and Boehncke WH (2003) The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. J Invest Dermatol 121:951–962
Schroder K, Hertzog PJ, Ravasi T, and Hume DA (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189
Schultz LF, Diepgen T, and Svensson A (1996) The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 34:760–764
Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, and Ihle JN (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630–633
Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, and Geha RS (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101:1614–1622
Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, and Geha RS (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103:1103–1111
Stoll S, Jonuleit H, Schmitt E, Muller G, Yamauchi H, Kurimoto M, Knop J, and Enk AH (1998) Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Thl development. Eur J Immunol 28:3231–3239
Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, and Ra C (1999) NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 120[Suppll]:70–75
Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, and Akira S (1996) Essential role of Stat6 in IL-4 signalling. Nature 380:627–630
Tan BB, Weald D, Strickland I, and Friedmann PS (1996) Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 347:15–18
Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, and Leder P (1990) IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62:457–467
Tortolani PJ, Lai BK, Riva A, Johnston JA, Chen YQ, Reaman GH, Beck-with M, Longo D, Ortaldo JR, and Bhatia K (1995) Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J Immunol 155:5220–5226
Tsudzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J, and Matsuda H (1997) Genetic analyses for dermatitis and IgE hyperproduction in the NC/Nga mouse. Immunogenetics 47:88–90
Tupker RA, de Monchy JG, Coenraads PJ, Homan A, and Van Der Meer JB (1996) Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 97:1064–1070
Valenta R, Natter S, Seiberler S, Wichlas S, Maurer D, Hess M, Pavelka M, Grote M, Ferreira F, Szepfalusi Z, Valent P, and Stingl G (1998) Molecular characterization of an autoallergen, Horn s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 111:1178–1183
Valenta R, Seiberler S, Natter S, Mahler V, Mossabeb R, Ring J, and Stingl G (2000) Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 105:432–437
Van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, and Mudde GC (1992) Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184–193
Van Reijsen FC, Felius A, Wauters EA, Bruijnzeel-Koomen CA, and Koppelman SJ (1998) T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis. J Allergy Clin Immunol 101:207–209
Vestergaard C, Yoneyama H, and Matsushima K (2000) The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today 6:209–210
Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, and Matsushima K (1999) Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104:1097–1105
Wang D, You Y, Case SM, McAllister-Lucas LM, Wang L, DiStefano PS, Nunez G, Bertin J, and Lin X (2002) A requirement for CARMA1 in TCR-induced NF-κB activation. Nat Immunol 3:830–835
Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M, and Fukuda Y (2002) Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol 128:229–234
Watanabe O, Natori K, Tamari M, Shiomoto Y, Kubo S, and Nakamura Y (1999) Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J Hum Genet 44:173–176
Watanabe O, Tamari M, Natori K, Onouchi Y, Shiomoto Y, Hiraoka I, and Nakamura Y (2001) Loci on murine chromosomes 7 and 13 that modify the phenotype of the NOA mouse, an animal model of atopic dermatitis. J Hum Genet 46:221–224
Wershil BK, Wang ZS, Gordon JR, and Galli SJ (1991) Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J Clin Invest 87:446–453
Williams CM and Galli SJ (2000) Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192:455–462
Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, and Ihle JN (1994) Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153–157
Wohlfahrt JG, Kunzmann S, Menz G, Kneist W, Akdis CA, Blaser K, and Schmidt-Weber CB (2003) T cell phenotype in allergic asthma and atopic dermatitis. Int Arch Allergy Immunol 131:272–282
Woodward AL, Spergel JM, Alenius H, Mizoguchi E, Bhan AK, Castigli E, Brodeur SR, Oettgen HC, and Geha RS (2001) An obligate role for T-cell receptor αβ + T cells but not T-cell receptor γδ + T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis. J Allergy Clin Immunol 107:359–366
Xiao T, Fujita H, Saeki H, Mitsui H, Sugaya M, Tada Y, Kakinuma T, Torii H, Nakamura K, Asahina A, and Tamaki K (2003) Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNFα and IL-4 and downregulated by IFNγ. Cytokine 23:126–132
Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, and Kubo M (2002) Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 168:2020–2027
Yamanaka K, Tanaka M, Tsutsui H, Kupper TS, Asahi K, Okamura H, Nakanishi K, Suzuki M, Kayagaki N, Black RA, Miller DK, Nakashima K, Shimizu M, and Mizutani H (2000) Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 165:997–1003
Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y, and Nakanishi K (1997) Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc Natl Acad Sci USA 94:3948–3953
Yoshioka T, Hikita I, Matsutani T, Yoshida R, Asakawa M, Toyosaki-Maeda T, Hirasawa T, Suzuki R, Arimura A, and Horikawa T (2003) DS-Nh as an experimental model of atopic dermatitis induced by Staphylococcus aureus producing staphylococcal enterotoxin C. Immunology 108:562–569
Zabeau L, Gevaert P, Bachert C, and Tavernier J (2003) Interleukin-5, eosinophilic diseases and therapeutic intervention. Curr Drug Targets Inflam Allergy 2:319–328
Zou GM and Tam YK (2002) Cytokines in the generation and maturation of dendritic cells: recent advances. Eur Cytokine Netw 13:186–199
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Brzoska, T., Luger, T.A. (2005). Murine Models of Atopic Dermatitis. In: Zollner, T., Renz, H., Asadullah, K. (eds) Animal Models of T Cell-Mediated Skin Diseases. Ernst Schering Research Foundation Workshop, vol 50. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26811-1_7
Download citation
DOI: https://doi.org/10.1007/3-540-26811-1_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21067-2
Online ISBN: 978-3-540-26811-6
eBook Packages: MedicineMedicine (R0)